Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 20,392 shares at $20.34 ($415K) on 2024-05-01, disclosed to the SEC on 2024-05-03.
Scheduled sale ($415k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.91 | 1,357 | $27K | 6.5% |
| 2 | $20.34 | 9,035 | $184K | 44.3% |
| 3 | $20.34 | 9,035 | $184K | 44.3% |
| 4 | $20.87 | 965 | $20K | 4.9% |
| Total | $20.34 avg | 20,392 | $415K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-03 | $519K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $11K | — | Filing → |
| AVTE | SELL | 2023-08-01 | $99K | — | Filing → |